HarnettJ.D., FoleyR.N., KentG.M., BarreP.E., MurrayD., ParfreyP.S.Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.Kidney Int1995; 47: 884–90.
2.
ParfreyP.S., FoleyR.N., HarnettJ.D., KentG.M., MurrayD., BarreP.E.Outcome and risk factors of ischemic heart disease in chronic uremia.Kidney Int1996; 49: 1428–34.
3.
BestP.J., HolmesD.R.Jr.Chronic kidney disease as a cardiovascular risk factor.Am Heart J2003; 145: 383–6.
4.
HerzogC.A., MaJ.Z., CollinsA.J.Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.N Engl J Med1998; 339: 799–805.
5.
GoA.S., ChertowG.M., FanD., McCullochC.E., HsuC.Y.Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.N Engl J Med2004; 351: 1296–305.
6.
O'HareA.M., HsuC.Y., BacchettiP., JohansenK.L.Peripheral vascular disease risk factors among patients undergoing hemodialysis.J Am Soc Nephrol2002; 13: 497–503.
7.
MattanaJ., EffiongC., GooneratneR., SinghalP.C.Risk of fatal cerebrovascular accident in patients on peritoneal dialysis versus hemodialysis.J Am Soc Nephrol1997; 8: 1342–7.
8.
GlorieuxG.L., DhondtA.W., JacobsP., Van LangeraertJ., LameireN.H., De DeynP.P.In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.Kidney Int2004; 65: 2184–92.
CulletonB.F., LarsonM.G., WilsonP.W., EvansJ.C., ParfreyP.S., LevyD.Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.Kidney Int1999; 56: 2214–19.
11.
VanholderR., MassyZ., ArgilesA., SpasovskiG., VerbekeF., LameireN.Chronic kidney disease as cause of cardiovascular morbidity and mortality.Nephrol Dial Transplant2005; 20: 1048–56.
12.
GaneshS.K., Hulbert-ShearonT., PortF.K., EagleK., StackA.G.Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.J Am Soc Nephrol2003; 14: 415–24.
13.
StackA.G., MolonyD.A., RahmanN.S., DosekunA., MurthyB.Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.Kidney Int2003; 64: 1071–9.
14.
BleyerA.J., RussellG.B., SatkoS.G.Sudden and cardiac death rates in hemodialysis patients.Kidney Int1999; 55: 1553–9.
MoistL.M., PortF.K., OrzolS.M., YoungE.W., OstbyeT., WolfeR.A.Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol2000; 11: 556–64.
17.
FriedlanderM.A., WuY.C., SchulakJ.A., MonnierV.M., HricikD.E.Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.Am J Kidney Dis1995; 25: 445–51.
18.
ZeierM., SchwengerV., DeppischR., HaugU., WeigelK., BahnerU.Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Kidney Int2003; 63: 298–305.
19.
DikowR., SchwengerV., ZeierM., RitzE.Do AV fistulas contribute to cardiac mortality in hemodialysis patients?Semin Dial2002; 15: 14–17.
20.
HuangJ.W., YenC.J., ChiangH.W., HungK.Y., TsaiT.J., WuK.D.Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function.Am J Kidney Dis2004; 43: 1047–55.
21.
PrichardS.Cardiovascular risk in peritoneal dialysis.Contrib Nephrol2003; 140: 82–90.
22.
PrinsenB.H., RabelinkT.J., RomijnJ.A., BisschopP.H., de BarseM.M., de BoerJ.A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.Kidney Int2004; 65: 1064–75.
23.
MalyszkoJ., MalyszkoJ.S., MysliwiecM.Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.Perit Dial Int2001; 21: 158–65.
24.
KobayashiM., YoriokaN., YamakidoM.Hypercoagulability and secondary hyperfibrinolysis may be related to abnormal lipid metabolism in patients treated with continuous ambulatory peritoneal dialysis.Nephron1997; 76: 56–61.
25.
LocatelliF., MarcelliD., ConteF., D'AmicoM., Del VecchioL., LimidoA.Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease.J Am Soc Nephrol2001; 12: 2411–17.
26.
FoleyR.N., ParfreyP.S., HarnettJ.D., KentG.M., O'DeaR., MurrayD.C.Mode of dialysis therapy and mortality in end-stage renal disease.J Am Soc Nephrol1998; 9: 267–76.
27.
Van BiesenW., VanholderR.C., VeysN., DhondtA., LameireN.H.An evaluation of an integrative care approach for end-stage renal disease patients.J Am Soc Nephrol2000; 11: 116–25.
28.
VoneshE.F., SnyderJ.J., FoleyR.N., CollinsA.J.The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.Kidney Int2004; 66: 2389–401.
29.
CollinsA.J., KasiskeB., HerzogC., ChaversB., FoleyR., GilbertsonD.Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.Am J Kidney Dis2005; 45: A5–A7.
30.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 184–91.
31.
VoneshE.F., MoranJ.Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1999; 10: 354–65.
32.
Van BiesenW., VanholderR., DebacquerD., De BackerG., LameireN.Comparison of survival on CAPD and haemodialysis: statistical pitfalls.Nephrol Dial Transplant2000; 15: 307–11.
33.
ChurchillD.N., ThorpeK.E., VoneshE.F., KeshaviahP.R.Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1997; 8: 965–71.
34.
GuoA., MujaisS.Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts.Kidney Int Suppl2003; 88: S3–12.
35.
IsekiK., KinjoK., KimuraY., OsawaA., FukiyamaK.Evidence for high risk of cerebral hemorrhage in chronic dialysis patients.Kidney Int1993; 44: 1086–90.
36.
SeligerS.L., GillenD.L., TirschwellD., WasseH., KestenbaumB.R., Stehman-BreenC.O.Risk factors for incident stroke among patients with end-stage renal disease.J Am Soc Nephrol2003; 14: 2623–31.
37.
ShlipakM.G., HeidenreichP.A., NoguchiH., ChertowG.M., BrownerW.S., McClellanM.B.Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.Ann Intern Med2002; 137: 555–62.
38.
WrightR.S., ReederG.S., HerzogC.A., AlbrightR.C., WilliamsB.A., DvorakD.L.Acute myocardial infarction and renal dysfunction: a high-risk combination.Ann Intern Med2002; 137: 563–70.
39.
McCulloughP.A., SandbergK.R., BorzakS., HudsonM.P., GargM., ManleyH.J.Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.Am Heart J2002; 144: 226–32.
40.
FentonS.S., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates.Am J Kidney Dis1997; 30: 334–42.
41.
HeafJ.G., LokkegaardH., MadsenM.Initial survival advantage of peritoneal dialysis relative to haemodialysis.Nephrol Dial Transplant2002; 17: 112–17.
42.
TermorshuizenF., KorevaarJ.C., DekkerF.W., Van ManenJ.G., BoeschotenE.W., KredietR.T.Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2.J Am Soc Nephrol2003; 14: 2851–60.
43.
StackA.G., MurthyB.V., MolonyD.A.Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States.Kidney Int2004; 65: 2398–408.
44.
EniaG., MallamaciF., BenedettoF.A., PanuccioV., ParlongoS., CutrupiS.Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.Nephrol Dial Transplant2001; 16: 1459–64.
45.
WangA.Y., WangM., WooJ., LawM.C., ChowK.M., LiP.K.A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.Kidney Int2002; 62: 639–47.
46.
MenonM.K., NaimarkD.M., BargmanJ.M., VasS.I., OreopoulosD.G.Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.Nephrol Dial Transplant2001; 16: 2207–13.
KronenbergF., LingenhelA., NeyerU., LhottaK., KonigP., AuingerM.Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.Kidney Int Suppl2003; 84: S113–16.
49.
FoleyR.N., HerzogC.A., CollinsA.J.Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study.Kidney Int2003; 63: 1462–7.
50.
MasonN.A., BailieG.R., SatayathumS., Bragg-GreshamJ.L., AkibaT., AkizawaT.HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.Am J Kidney Dis2005; 45: 119–26.
51.
Van BiesenW., BoerW., De GreveB., DequidtC., VijtD., FaictD.A randomized clinical trial with a 0.6% amino acid/1.4% glycerol peritoneal dialysis solution.Perit Dial Int2004; 24: 222–30.
52.
GunalA.I., DumanS., OzkahyaM., TozH., AsciG., AkcicekF.Strict volume control normalizes hypertension in peritoneal dialysis patients.Am J Kidney Dis2001; 37: 588–93.
53.
MedcalfJ.F., HarrisK.P., WallsJ.Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.Kidney Int2001; 59: 1128–33.
54.
DaviesS.J., WoodrowG., DonovanK., PlumJ., WilliamsP., JohanssonA.C.Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.J Am Soc Nephrol2003; 14: 2338–44.
55.
KoningsC.J., KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.
56.
BrownE.A., DaviesS.J., RutherfordP., MeeusF., BorrasM., RiegelW.Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.J Am Soc Nephrol2003; 14: 2948–57.
57.
LinS.H., LinY.F., KuoS.W., HsuY.J., HungY.J.Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD.Am J Kidney Dis2003; 42: 774–80.
